Loading...

WuXi Biologics (Cayman) Inc.

WXIBFPNK
Healthcare
Biotechnology
$3.18
$0.00(0.00%)

WuXi Biologics (Cayman) Inc. WXIBF Peers

See (WXIBF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXIBF$3.18+0.00%12.9B28.91$0.11N/A
NONOF$68.97+2.03%303.6B18.89$3.62+2.41%
CSLLY$79.18+0.56%153.5B29.13$2.72+1.68%
CMXHF$151.02-7.39%73.1B27.71$5.45+1.83%
UCBJF$199.89+0.00%38B31.78$6.29+0.79%
UCBJY$98.27+0.02%37.3B31.17$3.15+0.80%
ARGNF$547.60+0.08%33.4B33.35$16.42N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$10.25-1.49%16.9B-1024.00-$0.01N/A
WXXWY$6.45-1.15%13.3B29.30$0.22N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXIBF vs NONOF Comparison

WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXIBF stands at 12.9B. In comparison, NONOF has a market cap of 303.6B. Regarding current trading prices, WXIBF is priced at $3.18, while NONOF trades at $68.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXIBF currently has a P/E ratio of 28.91, whereas NONOF's P/E ratio is 18.89. In terms of profitability, WXIBF's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, WXIBF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.

Stock Price Comparison

Loading...

Frequently Asked Questions

;